Menu Search
Equities

Zhejiang Shouxiangu Pharmaceutical Co Ltd

603896:SHH

Zhejiang Shouxiangu Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)18.99
  • Today's Change-0.25 / -1.30%
  • Shares traded2.08m
  • 1 Year change-55.38%
  • Beta1.0030
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 19-Sep-24
Select bar for recommendation details.
Recommendations19-Sep-24
Buy0
Outperform3
Hold0
Sell0
Strong Sell0

Share price forecast in CNY

The one analyst offering a 12 month price target expects Zhejiang Shouxiangu Pharmaceuticl Co Ltd share price to rise to 55.60 in the next year from the last price of 18.96.
High193.2%55.60
Med193.2%55.60
Low193.2%55.60

Dividends

In 2023, Zhejiang Shouxiangu Pharmaceutical Co Ltd reported a dividend of 0.39 CNY, which represents a 11.36% decrease from last year. The 4 analysts covering the company expect dividends of 0.42 CNY for the upcoming fiscal year, an increase of 8.46%.
Div growth (TTM)-11.36%
More ▼

Earnings history & estimates in CNY

Zhejiang Shouxiangu Pharmaceuticl Co Ltd reported annual 2023 earnings of 1.30 per share on Apr 25, 2024.
Average growth rate+19.11%
More ▼

Revenue history & estimates in CNY

Zhejiang Shouxiangu Pharmaceuticl Co Ltd had revenues for the full year 2023 of 784.35m. This was 5.39% below the prior year's results.
Average growth rate+9.90%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.